Citadel Advisors’s Quanome Technologies, Inc. Common Stock QNME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.2K Buy
26,049
+3,261
+14% +$2.59K ﹤0.01% 12690
2025
Q4
$20.3K Sell
22,788
-10,758
-32% -$11.3K ﹤0.01% 12341
2025
Q3
$43.3K Sell
33,546
-1,400
-4% -$1.38K ﹤0.01% 12261
2025
Q2
$29.7K Buy
34,946
+16,127
+86% +$15.6K ﹤0.01% 11980
2025
Q1
$20.3K Buy
+18,819
New +$33.5K ﹤0.01% 13132

Other funds holding QNME

Citadel Advisors's QNME Position: Q1 2026 in Review

Citadel Advisors increased its Quanome Technologies, Inc. Common Stock (QNME) stake by 14% in Q1 2026, buying an estimated $2.59K and bringing the position to 26,049 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #12690.

Citadel Advisors first reported a position in QNME in Q1 2025 and has held it in 5 quarters since. The position peaked at $43.3K in Q3 2025. 7 funds tracked by Wall St. Rank hold QNME as of Q1 2026.

  • Citadel Advisors held 26,049 shares of Quanome Technologies, Inc. Common Stock worth $18.2K as of Q1 2026.
  • Citadel Advisors bought 3,261 Quanome Technologies, Inc. Common Stock shares in Q1 2026, an estimated $2.59K.
  • Quanome Technologies, Inc. Common Stock made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12690 holding.
  • Citadel Advisors first reported a position in Quanome Technologies, Inc. Common Stock in Q1 2025 and has held it in 5 quarters since.
  • Citadel Advisors's Quanome Technologies, Inc. Common Stock position peaked at $43.3K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Quanome Technologies, Inc. Common Stock as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.